WO2001087280A3 - Mittel zur schubtherapie von autoimmunerkrankungen - Google Patents

Mittel zur schubtherapie von autoimmunerkrankungen Download PDF

Info

Publication number
WO2001087280A3
WO2001087280A3 PCT/EP2001/004965 EP0104965W WO0187280A3 WO 2001087280 A3 WO2001087280 A3 WO 2001087280A3 EP 0104965 W EP0104965 W EP 0104965W WO 0187280 A3 WO0187280 A3 WO 0187280A3
Authority
WO
WIPO (PCT)
Prior art keywords
immune diseases
auto
attacks
treating
treating attacks
Prior art date
Application number
PCT/EP2001/004965
Other languages
English (en)
French (fr)
Other versions
WO2001087280A2 (de
Inventor
Volker Neuser
Thomas Fahrig
Original Assignee
Bayer Ag
Volker Neuser
Thomas Fahrig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Volker Neuser, Thomas Fahrig filed Critical Bayer Ag
Priority to AU2001262252A priority Critical patent/AU2001262252A1/en
Publication of WO2001087280A2 publication Critical patent/WO2001087280A2/de
Publication of WO2001087280A3 publication Critical patent/WO2001087280A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft die Verwendung von Kalziumkanalantagonisten, insbesondere Nimodipin, zur Herstellung von Arzneimitteln zur Schubtherapie von Autoimmunerkrankungen, insbesondere von Multipler Sklerose.
PCT/EP2001/004965 2000-05-15 2001-05-03 Mittel zur schubtherapie von autoimmunerkrankungen WO2001087280A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001262252A AU2001262252A1 (en) 2000-05-15 2001-05-03 Means for treating attacks of auto-immune diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10023766 2000-05-15
DE10023766.5 2000-05-15

Publications (2)

Publication Number Publication Date
WO2001087280A2 WO2001087280A2 (de) 2001-11-22
WO2001087280A3 true WO2001087280A3 (de) 2002-06-27

Family

ID=7642117

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/004965 WO2001087280A2 (de) 2000-05-15 2001-05-03 Mittel zur schubtherapie von autoimmunerkrankungen

Country Status (2)

Country Link
AU (1) AU2001262252A1 (de)
WO (1) WO2001087280A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470718B2 (en) 2000-10-03 2008-12-30 Albert Einstein College Of Medicine Of Yeshiva University Method for treating a demyelinating condition
GB0309509D0 (en) * 2003-04-25 2003-06-04 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966772A (en) * 1988-04-29 1990-10-30 Bayer Aktiengesellschaft DHP delayed release preparation
WO1992007564A2 (en) * 1990-10-30 1992-05-14 The Wellcome Foundation Limited Method of treating demyelinating disease
WO1995016450A1 (de) * 1993-12-16 1995-06-22 Dr. Rentschler Arzneimittel Gmbh & Co. Verwendung von pentoxifyllin zur behandlung von multipler sklerose
US5998448A (en) * 1995-05-02 1999-12-07 Bayer Aktiengeselechaft Combined preparations with vascular effect containing dihydropyridines acetylsalicylic acid nitroesters and vitamins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966772A (en) * 1988-04-29 1990-10-30 Bayer Aktiengesellschaft DHP delayed release preparation
WO1992007564A2 (en) * 1990-10-30 1992-05-14 The Wellcome Foundation Limited Method of treating demyelinating disease
WO1995016450A1 (de) * 1993-12-16 1995-06-22 Dr. Rentschler Arzneimittel Gmbh & Co. Verwendung von pentoxifyllin zur behandlung von multipler sklerose
US5998448A (en) * 1995-05-02 1999-12-07 Bayer Aktiengeselechaft Combined preparations with vascular effect containing dihydropyridines acetylsalicylic acid nitroesters and vitamins

Also Published As

Publication number Publication date
AU2001262252A1 (en) 2001-11-26
WO2001087280A2 (de) 2001-11-22

Similar Documents

Publication Publication Date Title
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
IL160440A0 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
WO2002070438A3 (en) Compositions for delivering bisphosphonates
WO2001085715A3 (de) Aza- und polyazanthranylamide und deren verwendung als arzneimittel
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
GB0111186D0 (en) Novel compounds
MXPA03011546A (es) Formulacion farmaceutica.
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
PL374080A1 (en) Processes for the preparation of fibrinogen
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2004031202A3 (de) Kondensierte palatinose in hydrierter form
HUP0500137A2 (en) Pyrrolidine-2-ones as factor xa inhibitors, process for producing them and pharmaceutical compositions containing the same
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
WO2001049654A3 (de) Substituierte aminomethyl-phenyl-cyclohexanderivate
MXPA03006648A (es) Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2001049651A3 (de) Aminomethyl-phenyl-cyclohexanonderivate
MXPA03008211A (es) Predispersiones, proceso para su preparacion, composiciones para las mismas, proceso para la preparacion de tales composiciones..
WO2001087280A3 (de) Mittel zur schubtherapie von autoimmunerkrankungen
WO2004078142A3 (en) Compositions and methods for preventing and treating endotoxin-related diseases and conditions
AU2002254930A1 (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists
SE0001631D0 (sv) New use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP